SEC Form 4 · accession 0001144204-17-019305
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 9:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 3, 2017 | A | 2,381 | — | A | 2,739,435 | I | By Taurus |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of common stock were issued to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter.